Autoimmune Lymphoproliferative Syndrome in Children with Nonmalignant Organomegaly, Chronic Immune Cytopenia, and Newly Diagnosed Lymphoma

This study investigated the frequency of and predictive factors for autoimmune lymphoproliferative syndrome (ALPS) in children with lymphoma, chronic immune cytopenia, and nonmalignant organomegaly. Thirty-four children with suspected ALPS (n=13, lymphoma; n=12, immune cytopenia; n=9, nonmalignant o...

Full description

Bibliographic Details
Main Authors: Zühre Kaya, Melek Işık, Nihan Oruklu, Serap Kirkiz, Emin Ümit Bağrıaçık, Luis M. Allende, María J. Díaz-madroñero, Raquel Ruiz-García, Faruk Güçlü Pınarlı, Pınar Göçün Uyar, Ülker Koçak
Format: Article
Language:English
Published: Galenos Publishing House 2021-06-01
Series:Turkish Journal of Hematology
Subjects:
Online Access:https://jag.journalagent.com/z4/download_fulltext.asp?pdir=tjh&un=TJH-41514
_version_ 1797912336583884800
author Zühre Kaya
Melek Işık
Nihan Oruklu
Serap Kirkiz
Emin Ümit Bağrıaçık
Luis M. Allende
María J. Díaz-madroñero
Raquel Ruiz-García
Faruk Güçlü Pınarlı
Pınar Göçün Uyar
Ülker Koçak
author_facet Zühre Kaya
Melek Işık
Nihan Oruklu
Serap Kirkiz
Emin Ümit Bağrıaçık
Luis M. Allende
María J. Díaz-madroñero
Raquel Ruiz-García
Faruk Güçlü Pınarlı
Pınar Göçün Uyar
Ülker Koçak
author_sort Zühre Kaya
collection DOAJ
description This study investigated the frequency of and predictive factors for autoimmune lymphoproliferative syndrome (ALPS) in children with lymphoma, chronic immune cytopenia, and nonmalignant organomegaly. Thirty-four children with suspected ALPS (n=13, lymphoma; n=12, immune cytopenia; n=9, nonmalignant organomegaly) were included. Double-negative T-cells, lymphocyte apoptosis, and genetic findings were analyzed. Patients were stratified into two groups as proven/probable ALPS and clinically suspected patients according to the ALPS diagnostic criteria. Of the 34 patients, 18 (53%) were diagnosed with proven/probable ALPS. One patient had a mutation (c.652-2A>C) in the FAS gene. The remaining 16 (47%) patients were defined as clinically suspected patients. Predictive factors for ALPS were anemia and thrombocytopenia in patients with lymphoma, splenomegaly and lymphadenopathy in patients with immune cytopenia, and young age in patients with nonmalignant organomegaly. ALPS may not be rare in certain risk groups. Our study indicates that screening for ALPS may be useful in children having lymphoma with cytopenia at diagnosis, in those having nonmalignant organomegaly with immune cytopenia, and in those having chronic immune thrombocytopenic purpura or autoimmune hemolytic anemia with organomegaly developing during follow-up.
first_indexed 2024-04-10T11:54:24Z
format Article
id doaj.art-fe0b60ef578d4432ba9a9b45506dbc8b
institution Directory Open Access Journal
issn 1308-5263
language English
last_indexed 2024-04-10T11:54:24Z
publishDate 2021-06-01
publisher Galenos Publishing House
record_format Article
series Turkish Journal of Hematology
spelling doaj.art-fe0b60ef578d4432ba9a9b45506dbc8b2023-02-15T16:16:54ZengGalenos Publishing HouseTurkish Journal of Hematology1308-52632021-06-0138214515010.4274/tjh.galenos.2020.2020.0618TJH-41514Autoimmune Lymphoproliferative Syndrome in Children with Nonmalignant Organomegaly, Chronic Immune Cytopenia, and Newly Diagnosed LymphomaZühre Kaya0Melek Işık1Nihan Oruklu2Serap Kirkiz3Emin Ümit Bağrıaçık4Luis M. Allende5María J. Díaz-madroñero6Raquel Ruiz-García7Faruk Güçlü Pınarlı8Pınar Göçün Uyar9Ülker Koçak10Gazi University Faculty of Medicine, Department of Pediatric Hematology, Ankara, TurkeyGazi University Faculty of Medicine, Department of Pediatric Hematology, Ankara, TurkeyGazi University Faculty of Medicine, Department of Immunology and Life Science Research Center, Ankara, TurkeyGazi University Faculty of Medicine, Department of Pediatric Hematology, Ankara, TurkeyGazi University Faculty of Medicine, Department of Immunology and Life Science Research Center, Ankara, TurkeyImmunology Department and Research Institute i+12, Hospital Universitario 12 de Octubre, Madrid, SpainImmunology Department and Research Institute i+12, Hospital Universitario 12 de Octubre, Madrid, SpainImmunology Department and Research Institute i+12, Hospital Universitario 12 de Octubre, Madrid, SpainGazi University Faculty of Medicine, Department of Pediatric Oncology, Ankara, TurkeyGazi University Faculty of Medicine, Department of Pathology, Ankara, TurkeyGazi University Faculty of Medicine, Department of Pediatric Hematology, Ankara, TurkeyThis study investigated the frequency of and predictive factors for autoimmune lymphoproliferative syndrome (ALPS) in children with lymphoma, chronic immune cytopenia, and nonmalignant organomegaly. Thirty-four children with suspected ALPS (n=13, lymphoma; n=12, immune cytopenia; n=9, nonmalignant organomegaly) were included. Double-negative T-cells, lymphocyte apoptosis, and genetic findings were analyzed. Patients were stratified into two groups as proven/probable ALPS and clinically suspected patients according to the ALPS diagnostic criteria. Of the 34 patients, 18 (53%) were diagnosed with proven/probable ALPS. One patient had a mutation (c.652-2A>C) in the FAS gene. The remaining 16 (47%) patients were defined as clinically suspected patients. Predictive factors for ALPS were anemia and thrombocytopenia in patients with lymphoma, splenomegaly and lymphadenopathy in patients with immune cytopenia, and young age in patients with nonmalignant organomegaly. ALPS may not be rare in certain risk groups. Our study indicates that screening for ALPS may be useful in children having lymphoma with cytopenia at diagnosis, in those having nonmalignant organomegaly with immune cytopenia, and in those having chronic immune thrombocytopenic purpura or autoimmune hemolytic anemia with organomegaly developing during follow-up.https://jag.journalagent.com/z4/download_fulltext.asp?pdir=tjh&un=TJH-41514autoimmune lymphoproliferative syndromeimmune cytopenialymphoma
spellingShingle Zühre Kaya
Melek Işık
Nihan Oruklu
Serap Kirkiz
Emin Ümit Bağrıaçık
Luis M. Allende
María J. Díaz-madroñero
Raquel Ruiz-García
Faruk Güçlü Pınarlı
Pınar Göçün Uyar
Ülker Koçak
Autoimmune Lymphoproliferative Syndrome in Children with Nonmalignant Organomegaly, Chronic Immune Cytopenia, and Newly Diagnosed Lymphoma
Turkish Journal of Hematology
autoimmune lymphoproliferative syndrome
immune cytopenia
lymphoma
title Autoimmune Lymphoproliferative Syndrome in Children with Nonmalignant Organomegaly, Chronic Immune Cytopenia, and Newly Diagnosed Lymphoma
title_full Autoimmune Lymphoproliferative Syndrome in Children with Nonmalignant Organomegaly, Chronic Immune Cytopenia, and Newly Diagnosed Lymphoma
title_fullStr Autoimmune Lymphoproliferative Syndrome in Children with Nonmalignant Organomegaly, Chronic Immune Cytopenia, and Newly Diagnosed Lymphoma
title_full_unstemmed Autoimmune Lymphoproliferative Syndrome in Children with Nonmalignant Organomegaly, Chronic Immune Cytopenia, and Newly Diagnosed Lymphoma
title_short Autoimmune Lymphoproliferative Syndrome in Children with Nonmalignant Organomegaly, Chronic Immune Cytopenia, and Newly Diagnosed Lymphoma
title_sort autoimmune lymphoproliferative syndrome in children with nonmalignant organomegaly chronic immune cytopenia and newly diagnosed lymphoma
topic autoimmune lymphoproliferative syndrome
immune cytopenia
lymphoma
url https://jag.journalagent.com/z4/download_fulltext.asp?pdir=tjh&un=TJH-41514
work_keys_str_mv AT zuhrekaya autoimmunelymphoproliferativesyndromeinchildrenwithnonmalignantorganomegalychronicimmunecytopeniaandnewlydiagnosedlymphoma
AT melekisık autoimmunelymphoproliferativesyndromeinchildrenwithnonmalignantorganomegalychronicimmunecytopeniaandnewlydiagnosedlymphoma
AT nihanoruklu autoimmunelymphoproliferativesyndromeinchildrenwithnonmalignantorganomegalychronicimmunecytopeniaandnewlydiagnosedlymphoma
AT serapkirkiz autoimmunelymphoproliferativesyndromeinchildrenwithnonmalignantorganomegalychronicimmunecytopeniaandnewlydiagnosedlymphoma
AT eminumitbagrıacık autoimmunelymphoproliferativesyndromeinchildrenwithnonmalignantorganomegalychronicimmunecytopeniaandnewlydiagnosedlymphoma
AT luismallende autoimmunelymphoproliferativesyndromeinchildrenwithnonmalignantorganomegalychronicimmunecytopeniaandnewlydiagnosedlymphoma
AT mariajdiazmadronero autoimmunelymphoproliferativesyndromeinchildrenwithnonmalignantorganomegalychronicimmunecytopeniaandnewlydiagnosedlymphoma
AT raquelruizgarcia autoimmunelymphoproliferativesyndromeinchildrenwithnonmalignantorganomegalychronicimmunecytopeniaandnewlydiagnosedlymphoma
AT farukguclupınarlı autoimmunelymphoproliferativesyndromeinchildrenwithnonmalignantorganomegalychronicimmunecytopeniaandnewlydiagnosedlymphoma
AT pınargocunuyar autoimmunelymphoproliferativesyndromeinchildrenwithnonmalignantorganomegalychronicimmunecytopeniaandnewlydiagnosedlymphoma
AT ulkerkocak autoimmunelymphoproliferativesyndromeinchildrenwithnonmalignantorganomegalychronicimmunecytopeniaandnewlydiagnosedlymphoma